5-MeO-PiPT

5-MeO-PiPT

Identifiers
IUPAC name N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(propan-2-yl)propan-1-amine
CAS Number	2945111-53-3  Y
PubChem CID	166468735
Chemical and physical data
Formula	C17H26N2O
Molar mass	274.408 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)N(CCC)CCc1c[NH]c2ccc(cc21)OC
InChI InChI=1S/C17H26N2O/c1-5-9-19(13(2)3)10-8-14-12-18-17-7-6-15(20-4)11-16(14)17/h6-7,11-13,18H,5,8-10H2,1-4H3 Key:KLRSMSBDLVDLKK-UHFFFAOYSA-N

5-Methoxy-N-propyl-N-isopropyltryptamine (5-MeO-PiPT) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It acts as a 5-HT_1A and 5-HT_2A receptor agonist, ^[1] with an EC₅₀ of 13.8 nM and an efficacy of 89% (vs 5-HT), ^[2] and has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada. ^[3]

See also

• 4-HO-PiPT
• 5-MeO-DPT
• 5-MeO-DiPT
• 5-MeO-MiPT
• 5-MeO-EiPT
• Propylisopropyltryptamine

References

1. Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D (June 2024). "Structural pharmacology and therapeutic potential of 5-methoxytryptamines". Nature. 630 (8015): 237–246. doi:10.1038/s41586-024-07403-2. PMC   11152992 . PMID   38720072.
2. Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115167
3. Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia's Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).